AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Arteris Inc. Shares Soar 63.07% on AMD Licensing Deal
Generated by AI AgentAinvest Pre-Market Radar
Tuesday, Aug 5, 2025 7:05 am ET1min read
Aime SummaryOn August 5, 2025,
Inc. (NASDAQ: AIP) shares surged 63.07% in pre-market trading, marking a significant rise in the company's stock value.Arteris' stock rally was driven by a licensing deal with
(AMD), where licensed Arteris' FlexGen network-on-chip (NoC) interconnect IP for its next-generation AI chiplet designs. This deal is expected to enhance the performance and efficiency of AMD's semiconductor products, particularly in the AI computing sector.The agreement between Arteris and AMD is seen as a strategic move that could boost Arteris' prospects, given AMD's broad AI computing portfolio. This partnership is anticipated to play a crucial role in AMD's future semiconductor designs, leveraging Arteris' technology to power AI across various applications from data centers to edge and end devices.
This licensing deal comes ahead of Arteris' Q2 earnings report, scheduled for August 5, 2025. The market is anticipating a slightly narrower loss per share for Arteris compared to the previous year, with revenue expected to rise year-over-year.
Ainvest Pre-Market Radar
Get the scoop on pre-market movers and shakers in the US stock market.
Latest Articles
Getty Images (NYSE:GETY) surges 5.51% on renewed investor confidence
Jan.02 2026
Olaplex Holdings (NASDAQ: OLPX) shares plunged 7.59% on mixed analyst outlooks and shifting institutional positioning.
Jan.02 2026
The Real Brokerage shares surge 7.04% on Jan. 2 2026 driven by regulatory tailwinds and restructuring optimism
Jan.02 2026
Vanda Pharmaceuticals shares surged 25.46% on partnership and FDA Breakthrough Therapy Designation.
Jan.02 2026
Vanda Pharmaceuticals shares surge 25.46% on partnership and FDA breakthrough designation
Jan.02 2026
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments

No comments yet